ASCT, CAR T-cell, or Combined Consolidation for R/R PCNSL in Re-achieved CR: An Inverse Probability of Treatment Weighting-Adjusted Comparative Study
{{output}}
Background: Chimeric antigen receptor (CAR) T-cell therapy has emerged as a promising strategy for treating relapsed or refractory primary central nervous system lymphoma (R/R PCNSL). While recent reports suggest that combined au... ...
